BTG gives product update

Tuesday 13 July 2010

BTC Plc expects to report data from a Phase 2a study of its oral multiple sclerosis treatment, Pleneva, in the first half of 2011. Meanwhile, it is making plans to take over US sales from Nycomed of two emergency care products in October, 2010.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom